Literature DB >> 18034428

Toll-like receptors' two-edged sword: when immunity meets apoptosis.

Bruno Salaun1, Pedro Romero, Serge Lebecque.   

Abstract

Toll-like receptors (TLR) have emerged as key players in the detection of pathogens and the induction of anti-microbial immune response. TLR recognize pathogen-associated molecular patterns, and trigger anti-microbial innate immune responses ranging from the secretion of pro-inflammatory mediators to the increase of natural killer cell cytotoxicity. Besides activating the innate immune response, TLR engagement also shapes the adaptive immune response. Indeed, the broad diversity of signaling pathways initiated by TLR is progressively unraveled. Recent reports suggested that among the anti-microbial defenses they initiate, members of the TLR family can induce apoptosis. This review focuses on this newly described function of TLR, and emphasizes the similarities and differences between the different apoptosis-signaling pathways described downstream of TLR. The functional relevance of TLR-triggered apoptosis is also discussed, as therapeutic applications are likely to ensue in the near future.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18034428     DOI: 10.1002/eji.200737744

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  70 in total

Review 1.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

Review 2.  Toll-like receptors and cancer.

Authors:  Seth Rakoff-Nahoum; Ruslan Medzhitov
Journal:  Nat Rev Cancer       Date:  2008-12-04       Impact factor: 60.716

Review 3.  Toll-like receptors in pregnancy disorders and placental dysfunction.

Authors:  Joan K Riley; D Michael Nelson
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

Review 4.  Controversial role of toll-like receptors in acute pancreatitis.

Authors:  Juan Vaz; Hamid Akbarshahi; Roland Andersson
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

5.  Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination.

Authors:  Zhenzhen Zhan; Xuefeng Xie; Hao Cao; Xiaohui Zhou; Xu Dong Zhang; Huimin Fan; Zhongmin Liu
Journal:  Autophagy       Date:  2013-12-04       Impact factor: 16.016

6.  Activation of NLRC4 downregulates TLR5-mediated antibody immune responses against flagellin.

Authors:  Wei Li; Jingyi Yang; Ejuan Zhang; Maohua Zhong; Yang Xiao; Jie Yu; Dihan Zhou; Yuan Cao; Yi Yang; Yaoming Li; Huimin Yan
Journal:  Cell Mol Immunol       Date:  2015-04-27       Impact factor: 11.530

7.  Recurrent overexpression of c-IAP2 in EBV-associated nasopharyngeal carcinomas: critical role in resistance to Toll-like receptor 3-mediated apoptosis.

Authors:  Luc Friboulet; Catherine Pioche-Durieu; Sandrine Rodriguez; Alexander Valent; Sylvie Souquère; Hugues Ripoche; Abdelmajid Khabir; Sai Wah Tsao; Jacques Bosq; Kwok Wai Lo; Pierre Busson
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

8.  Pregnancy Alters Innate and Adaptive Immune Responses to Zika Virus Infection in the Reproductive Tract.

Authors:  Kelsey E Lesteberg; Dana S Fader; J David Beckham
Journal:  J Immunol       Date:  2020-10-30       Impact factor: 5.422

9.  Glycosylation of Candida albicans cell wall proteins is critical for induction of innate immune responses and apoptosis of epithelial cells.

Authors:  Jeanette Wagener; Günther Weindl; Piet W J de Groot; Albert D de Boer; Susanne Kaesler; Selvam Thavaraj; Oliver Bader; Daniela Mailänder-Sanchez; Claudia Borelli; Michael Weig; Tilo Biedermann; Julian R Naglik; Hans Christian Korting; Martin Schaller
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

Review 10.  Type I interferon: friend or foe?

Authors:  Giorgio Trinchieri
Journal:  J Exp Med       Date:  2010-09-13       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.